UA73763C2 - Carbohydrate composition containing prebiotic for treatment or prevention of measles - Google Patents

Carbohydrate composition containing prebiotic for treatment or prevention of measles Download PDF

Info

Publication number
UA73763C2
UA73763C2 UA2002097766A UA2002097766A UA73763C2 UA 73763 C2 UA73763 C2 UA 73763C2 UA 2002097766 A UA2002097766 A UA 2002097766A UA 2002097766 A UA2002097766 A UA 2002097766A UA 73763 C2 UA73763 C2 UA 73763C2
Authority
UA
Ukraine
Prior art keywords
composition
composition according
prebiotic
milk
agent
Prior art date
Application number
UA2002097766A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of UA73763C2 publication Critical patent/UA73763C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UA2002097766A 2000-03-01 2001-02-14 Carbohydrate composition containing prebiotic for treatment or prevention of measles UA73763C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
UA73763C2 true UA73763C2 (en) 2005-09-15

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002097766A UA73763C2 (en) 2000-03-01 2001-02-14 Carbohydrate composition containing prebiotic for treatment or prevention of measles

Country Status (21)

Country Link
US (2) US20030040492A1 (de)
EP (1) EP1261355B1 (de)
JP (1) JP4838477B2 (de)
KR (1) KR20020081375A (de)
CN (1) CN1243551C (de)
AR (1) AR027968A1 (de)
AT (1) ATE283697T1 (de)
AU (2) AU3174601A (de)
BR (1) BR0108828A (de)
CA (1) CA2400969C (de)
DE (1) DE60107544T2 (de)
ES (1) ES2232591T3 (de)
HU (1) HUP0204546A3 (de)
IL (1) IL151280A0 (de)
MX (1) MXPA02008447A (de)
NO (1) NO20024011L (de)
PL (1) PL365136A1 (de)
PT (1) PT1261355E (de)
UA (1) UA73763C2 (de)
WO (1) WO2001064225A1 (de)
ZA (1) ZA200207849B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008046625A2 (en) * 2006-10-18 2008-04-24 Dsm Ip Assets B.V. Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (de) * 2007-08-24 2010-05-26 Barry Callebaut AG Verfahren und hiermit hergestelltes konfektprodukt
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2009151331A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Immune system stimulating nutrition
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN107087793A (zh) 2009-07-15 2017-08-25 N·V·努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
EP2813230A1 (de) 2009-07-15 2014-12-17 N.V. Nutricia Fucosyllactose als muttermilchidentisches unverdauliches Oligosaccharid zur Vorbeugung und/oder Behandlung von Infektionen
DK2498626T3 (en) 2009-11-12 2015-07-13 Nestec Sa FOOD COMPOSITION TO PROMOTE GAS MICROFLORAL BALANCE AND HEALTH
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
BR112020004347A2 (pt) * 2017-09-08 2020-09-08 Evelo Biosciences, Inc. vesículas extracelulares de prevotella
AU2018330322A1 (en) 2017-09-08 2020-03-19 Evelo Biosciences, Inc. Bacterial extracellular vesicles
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113876935B (zh) * 2021-10-19 2025-11-04 深圳市红瑞生物科技有限公司 一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689071T2 (de) * 1985-10-31 1994-02-10 Univ Australian Immunheilbehandlung.
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
US7101553B2 (en) 2006-09-05
NO20024011D0 (no) 2002-08-22
AU2001231746C1 (en) 2005-10-06
JP2003533438A (ja) 2003-11-11
IL151280A0 (en) 2003-04-10
CN1422158A (zh) 2003-06-04
ZA200207849B (en) 2003-12-30
AU3174601A (en) 2001-09-12
ATE283697T1 (de) 2004-12-15
US20030040492A1 (en) 2003-02-27
HUP0204546A2 (en) 2003-05-28
US20040191234A1 (en) 2004-09-30
NO20024011L (no) 2002-08-22
CA2400969A1 (en) 2001-09-07
EP1261355B1 (de) 2004-12-01
BR0108828A (pt) 2002-12-10
AR027968A1 (es) 2003-04-16
DE60107544T2 (de) 2005-12-15
CN1243551C (zh) 2006-03-01
AU2001231746B2 (en) 2004-12-23
CA2400969C (en) 2011-04-19
WO2001064225A1 (en) 2001-09-07
EP1261355A1 (de) 2002-12-04
PL365136A1 (en) 2004-12-27
ES2232591T3 (es) 2005-06-01
HK1051650A1 (en) 2003-08-15
JP4838477B2 (ja) 2011-12-14
KR20020081375A (ko) 2002-10-26
DE60107544D1 (de) 2005-01-05
HUP0204546A3 (en) 2003-10-28
MXPA02008447A (es) 2002-12-13
PT1261355E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
CA2400969C (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine
AU2001231746A1 (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
ES2355754T3 (es) Composición nutricional.
TWI639387B (zh) 用於預防胃腸道受傷及/或促進胃腸道治癒之半乳寡糖
Rizzoli Nutritional influence on bone: role of gut microbiota
RU2740156C1 (ru) Способы улучшения роста полезных бактерий в желудочно-кишечном тракте
CN113662199A (zh) 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
TW201233334A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
TW201429477A (zh) 使用人乳寡糖之用於調節炎症之營養調配物
TW201304692A (zh) 增進有益微生物相生長之益生菌及人乳寡醣之合益素(synbiotic)組合
TW201438719A (zh) 改善壓力症狀之母乳寡糖
TW201438720A (zh) 增強學習及記憶力之膳食寡糖
RU2695699C2 (ru) Питательная композиция с низким содержанием среднецепочечных жирных кислот в определенных соотношениях и ее применение
van Leusen et al. Industrial applications of galactooligosaccharides
US20250205261A1 (en) Composition for controlling growth of bacteria in the intestinal tract and use thereof
RU2694195C2 (ru) Питательная композиция для применения при активации формирования и/или регенерации кишечника и/или печени
CN112806577B (zh) 产丁酸的益生元益生菌增效组合
HK1051650B (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
HK40064537A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2025005236A1 (ja) Fusobacterium属菌の制御用組成物及びその利用
TW201244721A (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
Veereman-Wauters Prebiotics as Infant Foods